TITLE

Cardiovascular: Heart tool boosts GP care

AUTHOR(S)
Robinson, Stephen
PUB. DATE
March 2014
SOURCE
GP: General Practitioner;3/31/2014, p50
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
GPs should use a new computer tool to estimate patients' lifetime risk of cardiovascular disease and intervene much earlier to reduce risk, experts have said.
ACCESSION #
95471394

 

Related Articles

  • Lifestyle interventions cut risk of CVD. Pownall, Mark // GP: General Practitioner;9/8/2006, p8 

    The article focuses on a study by EuroAction on lifestyle intervention to reduce risk factors of cardiovascular disease. 10,792 high risk cardiovascular patients from across Europe were studied and it was found out that lifestyle intervention by a trained nurse, alongwith a general practitioner,...

  • Research prompts call to improve GP advice over aspirin treatment. Kelly, Brian // Pulse;2/9/2004, Vol. 64 Issue 6, p19 

    Reports that aspirin is being prescribed to a substantial number of patients in Great Britain putting them at risk of potentially harmful side effects. Large number of patients with cardiovascular disease; Insufficient advice given by general practitioners to patients; Publication of the...

  • Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003. Bartholomeeusen, Stefaan; Vandenbroucke, Jan P.; Truyers, Carla; Buntinx, Frank // BMC Family Practice;2008, Vol. 9, Special section p1 

    Background: General Practitioners (GPs) play a central role in controlling an important risk factor for cardiovascular diseases, i.e. cholesterol levels in serum. In the past few decades different studies have been published on the effect of treating hyperlipidemia with statins. Guidelines for...

  • Communicating cardiovascular risk. Manis, Kosta // Pulse;Sep2014, p106 

    The article offers a three-stage guide for general practitioners (GPs) to use to communicate the risk of cardiovascular disease to patients. It mentions the need to assess the numeracy skills and reading level of the patient at the start of the consultation. It notes that the scepticism of the...

  • A simple computer program for guiding management of cardiovascular risk factors and prescribing. Hingorani, Aroon D; Vallance, Patrick // BMJ: British Medical Journal (International Edition);01/09/99, Vol. 318 Issue 7176, p101 

    Presents information on a study which describes and tests against trial data, a simple computer program for guiding management of cardiovascular risk factors and prescribing drugs. Main outcome measures; Results; Conclusion.

  • Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study. Søltoft Larsen, Kasper; Pottegård, Anton; Lindegaard, Hanne M.; Hallas, Jesper // PLoS ONE;1/11/2016, Vol. 11 Issue 1, p1 

    Background: Gout gives rise to increased risk of cardiovascular events. Gout attacks can be effectively prevented with urate lowering drugs, and allopurinol potentially reduces cardiovascular risk. What target level of urate is required to reduce cardiovascular risk is not known. Objectives: ...

  • Screening for increased cardiometabolic risk in primary care: a systematic review. den Engelsen, Corine; Koekkoek, Paula S.; Godefrooij, Merijn B.; Spigt, Mark G.; Rutten, Guy E. // British Journal of General Practice;Oct2014, Vol. 64 Issue 627, pe616 

    Background Many programmes to detect and prevent cardiovascular disease (CVD) have been performed, but the optimal strategy is not yet clear. Aim To present a systematic review of cardiometabolic screening programmes performed among apparently healthy people (not yet known to have CVD, diabetes,...

  • Framingham has 'no clinical utility'. Swan, David // Pulse;7/4/2012, Vol. 72 Issue 24, p12 

    The article offers information on the research which shows the need for general practitioners (GPs) to switch to QRISK2 algorithm for use in cardiovascular risk score than Framingham risk score because of the absence of clinical utility.

  • Should Family Physicians Follow the New ACC/AHA Cholesterol Treatment Guideline? Not Completely: Why It Is Right to Drop LDL-C Targets, but Wrong to Recommend Statins at a 7.5% 10-Year Risk. HAYWARD, RODNEY A. // American Family Physician;8/15/2014, Vol. 90 Issue 4, p223 

    The author discusses compliance of family physicians to the Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, introduced by the American College of Cardiology (ACC) and American Heart Association (AHA). Topics explored include the reduction...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics